Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

被引:95
作者
Stout, Natasha K. [1 ,2 ]
Knudsen, Amy B. [3 ,4 ]
Kong, Chung Yin [3 ,4 ]
McMahon, Pamela M. [3 ,4 ]
Gazelle, G. Scott [2 ,3 ,4 ]
机构
[1] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Harvard Pilgrim Hlth Care, Boston, MA 02215 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Program Hlth Decis Sci, Boston, MA 02215 USA
[3] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
关键词
COST-EFFECTIVENESS ANALYSIS; HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY MODEL; BREAST-CANCER; CERVICAL-CANCER; COLORECTAL-CANCER; PROSTATE-CANCER; LUNG-CANCER; SCREENING STRATEGIES; CLINICAL BENEFITS;
D O I
10.2165/11314830-000000000-00000
中图分类号
F [经济];
学科分类号
02 ;
摘要
Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model's predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models. We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately. Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used. The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term 'calibration' was not always used, descriptions of calibration or 'model fitting' were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space. Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation.
引用
收藏
页码:533 / 545
页数:13
相关论文
共 186 条
[1]  
[Anonymous], 1998, HDB SIMULATION PRINC
[2]  
[Anonymous], 2003, J WOMENS IMAGING
[3]   Use of a mathematical model to evaluate breast cancer screening policy [J].
Baker R.D. .
Health Care Management Science, 1998, 1 (2) :103-113
[4]   Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme [J].
Beckett, JR ;
Kotre, CJ ;
Michaelson, JS .
BRITISH JOURNAL OF RADIOLOGY, 2003, 76 (905) :309-320
[5]   Radiation risk of mammography related to benefit in screening programmes: a favourable balance? [J].
Beemsterboer, PMM ;
Warmerdam, PG ;
Boer, R ;
de Koning, HJ .
JOURNAL OF MEDICAL SCREENING, 1998, 5 (02) :81-87
[6]   Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis [J].
Berkhof, J ;
de Bruijne, MC ;
Zielinski, GD ;
Bulkmans, NWJ ;
Rozendaal, L ;
Snijders, PJF ;
Verheijen, RHM ;
Meijer, CJLM .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) :1759-1768
[7]   Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands [J].
Berkhof, J ;
de Bruijne, MC ;
Zielinski, GD ;
Meijer, CJLM .
INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (02) :268-275
[8]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[9]  
Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006
[10]   Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival [J].
Blanchard, K ;
Colbert, JA ;
Puri, D ;
Weissman, J ;
Moy, B ;
Kopans, DB ;
Kaine, EM ;
Moore, RH ;
Halpern, EF ;
Hughes, KS ;
Tanabe, KK ;
Smith, BL ;
Michaelson, JS .
CANCER, 2004, 101 (03) :495-507